Cost-Effectiveness of the Addition of Rituximab to CHOP Chemotherapy in First-Line Treatment for Diffuse Large B-Cell Lymphoma in a Population-Based Observational Cohort in British Columbia, Canada
- Resource Type
- Article
- Source
- In
Value in Health 2010 13(6):703-711 - Subject
Economic Evaluation - Language
- ISSN
- 1098-3015